投稿热线:010-57289308
首页 >> 网络优先发表文章 >>文章 >> 健脾活血利水法治疗恶性腹水临床经验交流
详细内容

健脾活血利水法治疗恶性腹水临床经验交流

《中国中医药现代远程教育》[ISSN:1672-2779/CN:11-5024/R]

文章信息/Info

  • Title:健脾活血利水法治疗恶性腹水临床经验交流

  • 卷期:2024年22卷3期

  • 作者:付仁慧1  蔡新生2*

  • 1山东中医药大学2020级硕士研究生,山东 济南 250000;2. 潍坊市中医院肿瘤二科,山东潍坊,261000

  • Author(s):Furenhui 1 caixinsheng 2*

  • 1. 2020 master candidate of Shandong University of traditional Chinese medicine, Jinan, Shandong 250000; 2. the second Department of oncology, Weifang Hospital of traditional Chinese medicine, Weifang, Shandong, 261000

  • 关键词恶性腹水;健脾活血利水;临床经验交流

  • Keywords:malignant ascites; Invigorate the spleen and induce diuresis; Clinical experience exchange

  • 摘要:恶性腹水常见于恶性肿瘤晚期,多见于腹部、盆腔肿瘤如结直肠癌、卵巢癌、子宫内膜癌、胰腺癌等,其属中医“鼓胀”范畴。目前西医治疗手段有限,效果不佳,患者预后较差。中医认为恶性腹水主要病机为脾气虚弱、瘀水互结,在此基础上应用健脾活血利水法,同时使用抗肿瘤药物治本,在临床上取得了较好的疗效。                                                                                                                                                                                

  • Abstract:Malignant ascites is common in the late stage of malignant tumors, especially in abdominal and pelvic tumors such as colorectal cancer, ovarian cancer, endometrial cancer, pancreatic cancer, etc. It belongs to the category of "bloating" in traditional Chinese medicine. At present, western medicine treatment means are limited, the effect is poor, and the prognosis of patients is poor. It is considered that the main pathogenesis of malignant ascites in traditional Chinese medicine is weakness of spleen-qi and stagnation of blood stasis and water. On this basis, the method of invigorating spleen, promoting blood circulation and inducing diuresis is applied, and anti-tumor drugs are used to cure the root cause. Good clinical results have been achieved.

    恶性腹水作为恶性肿瘤晚期并发症之一,往往提示肿瘤进展、预后不佳[1]。这一病症极大影响了患者的生活质量以及治疗依从性,严重缩短了肿瘤患者的生存时间。且恶性腹水发展到后期常伴随着麻痹性肠梗阻、呼吸困难、脏器功能衰竭状态等严重并发症[2],往往造成患者的极大痛苦。

    参考文献/References:

    [1]孔志鹏. 中医治疗恶性腹水研究概况[J]. 实用中医药杂志, 2021, 37(03): 512-514.
    [2]陈熙, 邓恋. 多西他赛联合不同铂类腹腔化疗治疗恶性腹水效果观察[J]. 吉林医学, 2021, 42(10): 2438-2440.
    [3]李承慧, 龙婷婷, 汪超, et al. 恩度联合多西他赛序贯腹腔灌注治疗胃癌伴恶性腹水的临床观察[J]. 现代肿瘤医学, 2020, 28(01): 98-101.
    [4]王永斌, 邓智勇, 石洁, et al. 低三碘甲状腺原氨酸综合征与恶性肿瘤患者低蛋白血症严重程度的相关性研究[J]. 检验医学与临床, 2021, 18(20): 3013-3015.
    [5]黄燕, 谢益敏, 王皓, et al. 深部热疗联合腹腔灌注贝伐珠单抗治疗恶性腹水的疗效及对患者免疫功能的影响[J]. 吉林医学, 2021, 42(01): 69-72.

    seo seo